GlassScriptPhysician profile
Johnny Kao
NPI 1639141476
$14,544.24
in general payments reported to CMS, 2019-2025
17 companies · $31.35 in 2025
The $31.35 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,813 · 2020: $47.20 · 2021: $2,349 · 2022: $46.17 · 2023: $3,403 · 2024: $3,854 · 2025: $31.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,713 · Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,713.00 |
| Food and Beverage | $575.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12,141.64 | 2019-2024 | Imfinzi |
| Bayer Healthcare Pharmaceuticals INC. | $1,643.94 | 2019-2024 | |
| Novocure INC. | $316.08 | 2019-2025 | Optune, Optune Gio |
| Varian Medical Systems, INC. | $97.40 | 2019 | |
| Myriad Genetic Laboratories, INC. | $59.79 | 2023 | Prolaris |
| Tactile Systems Technology INC | $40.08 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $37.97 | 2024 | |
| Myovant Sciences INC. | $26.56 | 2021 | |
| Medtronic, INC. | $25.48 | 2022 | |
| Reflexion Medical, INC. | $25.00 | 2024 | Reflexion Medical Radiotherapy System |
| Carl Zeiss Meditec, INC. | $22.42 | 2020 | |
| Elekta, INC. | $21.62 | 2023 | Flexitron Hdr |
| Blue Earth Diagnostics | $20.69 | 2022 | |
| Boston Scientific Corporation | $20.06 | 2019 | |
| Fortovia Therapeutics, INC. | $17.06 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.24 | 2019 | |
| Genentech USA, INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Kao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.